Testing effectiveness (Phase 2)Study completedNCT01105403What this trial is testingExploratory Study on POL6326 in Stem Cell MobilizationWho this might be right forMultiple Myeloma Polyphor Ltd. 21
Not applicableStudy completedNCT00020527What this trial is testingCaspofungin Acetate in Treating Children With Fever and NeutropeniaWho this might be right forFever, Sweats, and Hot FlashesInfectionKidney Cancer+5 more National Cancer Institute (NCI)
Not applicableUnknownNCT04960761What this trial is testingThe Effectiveness of the Training Given With Audio and Picture Book Before the SurgeryWho this might be right forPediatric ALLAppendix Diseases Saglik Bilimleri Universitesi 70
Testing effectiveness (Phase 2)Study completedNCT00322842What this trial is testingTreatment With AMD3100 (Plerixafor) in Non-Hodgkin's Lymphoma and Multiple Myeloma PatientsWho this might be right forLymphoma, Non-HodgkinMultiple Myeloma Genzyme, a Sanofi Company 35
Early research (Phase 1)Study completedNCT00382954What this trial is testingPhase I Using Velcade & Idarubicin in Elderly and Relapsed AMLWho this might be right forAcute Myelogenous Leukemia University of Kentucky 55
Large-scale testing (Phase 3)Study completedNCT01259856What this trial is testingRandomized Trial of Pegylated Interferon Alfa-2a Versus Hydroxyurea in Polycythemia Vera (PV) and Essential Thrombocythemia (ET)Who this might be right forHigh Risk Polycythemia VeraHigh Risk Essential Thrombocythemia Ronald Hoffman 168
Testing effectiveness (Phase 2)Ended earlyNCT01783522What this trial is testingGlutamine in Preventing Peripheral Neuropathy in Patients With Multiple Myeloma Receiving BortezomibWho this might be right forChemotherapeutic Agent ToxicityMultiple MyelomaPeripheral Neuropathy Beth Faiman 9
Testing effectiveness (Phase 2)Ended earlyNCT02410551What this trial is testingPacritinib Before Transplant for Myeloproliferative Neoplasms (MPN)Who this might be right forMyeloproliferative Diseases M.D. Anderson Cancer Center 4
Testing effectiveness (Phase 2)WithdrawnNCT02355431What this trial is testingItacitinib in Combination With Erlotinib in Non Small Cell Lung Cancer Patients With Epidermal Growth Factor Receptor (EGFR) Activating MutationsWho this might be right forSolid Tumors and Hematologic MalignancyNSCLC (Non-small Cell Lung Carcinoma) Incyte Corporation
Not applicableStudy completedNCT01763502What this trial is testingThe Impact of Cash and Food Transfers Linked to Preschool Enrollment on Child Nutrition and Cognitive OutcomesWho this might be right forCognitive DevelopmentAnemia International Food Policy Research Institute 2,561
Not applicableStudy completedNCT03760237What this trial is testingCardiovascular Function in Acute LeukemiaWho this might be right forLeukemia, Myeloid, AcuteLeukemia, Lymphoid, AcuteCardiotoxicity Abramson Cancer Center at Penn Medicine 84
Testing effectiveness (Phase 2)Study completedNCT00576979What this trial is testingIntensity-Modulated Radiation Therapy, Etoposide, and Cyclophosphamide Followed By Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myeloid LeukemiaWho this might be right forLeukemia City of Hope Medical Center 51
Not applicableStudy completedNCT03054662What this trial is testingNon Substitutive Strategies to Improve Haemophilia Care in Developing Countries. Experience in Ivory Coast.Who this might be right forHaemophiliaDeveloping Countries Cliniques universitaires Saint-Luc- Université Catholique de Louvain 142
Not applicableNo Longer AvailableNCT00720603What this trial is testingThis is a Multi-center, Single Arm, Open Label Study Intended to Provide Expanded Access to Plerixafor for Patients With Non-Hodgkin's Lymphoma (NHL), Hodgkin's Disease (HD) or Multiple Myeloma (MM) Who Are to Receive Treatment With an Autologous Peripheral Stem Cell Transplant.Who this might be right forNon-Hodgkin's LymphomaHodgkin's DiseaseMultiple Myeloma Genzyme, a Sanofi Company
Testing effectiveness (Phase 2)Study completedNCT00042003What this trial is testingPhase II Trial of Decitabine in Patients With Chronic Myelogenous Leukemia Blast Phase Who Are Refractory to Imatinib Mesylate (Gleevec)Who this might be right forChronic Myelogenous Leukemia Astex Pharmaceuticals, Inc. 40
Testing effectiveness (Phase 2)UnknownNCT02937103What this trial is testingA Clinical Research of CD123-Targeted CAR-T in Myeloid MalignanciesWho this might be right forLeukemia Southwest Hospital, China 45
Not applicableLooking for participantsNCT06697483What this trial is testingRisk Stratification and MRD-driven Maintenance for MM After ASCTWho this might be right forMultiple Myeloma Peking University People's Hospital 100
Not applicableUnknownNCT06271005What this trial is testingNeurological Dry Eye Study Stimulating Both Lacrimal and Vagus NervesWho this might be right forDry Eye DiseaseDry Eye Genetic Disease Investigators 75
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06744894What this trial is testingSIL as Maintenance Therapy in Multiple MyelomaWho this might be right forMultiple Myeloma Navy General Hospital, Beijing 50
Not applicableStudy completedNCT01816256What this trial is testingScreening for Asymptomatic Portal Vein Thrombosis and Portal Hypertension in Patients With Philadelphia Negative Myeloproliferative NeoplasmsWho this might be right forMyeloproliferative Neoplasms (MPN)Polycythemia Vera (PV)Essential Thrombocythemia (ET)+1 more University Health Network, Toronto 102